Asymmetric Dimethylarginine: Relationship with Circulating Biomarkers of Inflammation and Cardiovascular Disease Risk in Uncomplicated Obese Women

In recent years, the link between obesity, inflammation and atherosclerosis has attracted increasing interest. Recently, besides the classical inflammatory markers, the competitive nitric oxide synthase antagonist asymmetric dimethylarginine (ADMA) has been shown to be involved in the pathogenesis o...

Full description

Bibliographic Details
Main Authors: E. Dozio, A.E. Malavazos, G. Dogliotti, S. Goggi, E. Galliera, U. Solimene, P. Magni, E. Costa, L. Morricone, M.M. Corsi
Format: Article
Language:English
Published: SAGE Publishing 2011-09-01
Series:European Journal of Inflammation
Online Access:https://doi.org/10.1177/1721727X1100900305